GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanall Biopharma Co Ltd (XKRX:009420) » Definitions » Cyclically Adjusted Book per Share

Hanall Biopharma Co (XKRX:009420) Cyclically Adjusted Book per Share : ₩2,767.67 (As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Hanall Biopharma Co Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Hanall Biopharma Co's adjusted book value per share for the three months ended in Dec. 2023 was ₩3,673.446. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₩2,767.67 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Hanall Biopharma Co's average Cyclically Adjusted Book Growth Rate was 8.90% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 9.70% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 8.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Hanall Biopharma Co was 9.70% per year. The lowest was 3.90% per year. And the median was 8.10% per year.

As of today (2024-04-28), Hanall Biopharma Co's current stock price is ₩34750.00. Hanall Biopharma Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was ₩2,767.67. Hanall Biopharma Co's Cyclically Adjusted PB Ratio of today is 12.56.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hanall Biopharma Co was 21.95. The lowest was 5.28. And the median was 11.54.


Hanall Biopharma Co Cyclically Adjusted Book per Share Historical Data

The historical data trend for Hanall Biopharma Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hanall Biopharma Co Cyclically Adjusted Book per Share Chart

Hanall Biopharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,939.43 2,098.41 2,334.02 2,542.64 2,767.67

Hanall Biopharma Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,542.64 2,595.43 2,638.65 2,726.40 2,767.67

Competitive Comparison of Hanall Biopharma Co's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Hanall Biopharma Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanall Biopharma Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanall Biopharma Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Hanall Biopharma Co's Cyclically Adjusted PB Ratio falls into.



Hanall Biopharma Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hanall Biopharma Co's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book= Book Value per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=3673.446/118.8477*118.8477
=3,673.446

Current CPI (Dec. 2023) = 118.8477.

Hanall Biopharma Co Quarterly Data

Book Value per Share CPI Adj_Book
201403 1,471.973 99.253 1,762.572
201406 1,479.081 99.353 1,769.301
201409 1,482.550 99.608 1,768.911
201412 1,139.226 99.098 1,366.268
201503 1,149.603 99.720 1,370.113
201506 1,182.920 100.050 1,405.171
201509 2,048.793 100.110 2,432.268
201512 1,904.252 100.220 2,258.192
201603 2,008.593 100.560 2,373.873
201606 2,050.235 100.790 2,417.558
201609 2,045.925 101.460 2,396.545
201612 2,044.906 101.560 2,392.993
201703 2,038.646 102.850 2,355.745
201706 2,049.151 102.610 2,373.423
201709 2,103.922 103.490 2,416.140
201712 2,172.814 102.990 2,507.369
201803 2,188.861 104.100 2,498.954
201806 2,244.162 104.130 2,561.351
201809 2,296.318 105.650 2,583.172
201812 2,284.590 104.350 2,601.996
201903 2,352.911 104.490 2,676.218
201906 2,438.149 104.880 2,762.857
201909 2,545.592 105.200 2,875.834
201912 2,743.767 105.120 3,102.078
202003 2,841.916 105.540 3,200.258
202006 3,063.382 104.870 3,471.688
202009 3,284.973 106.200 3,676.191
202012 3,541.937 105.765 3,980.045
202103 3,193.019 107.357 3,534.770
202106 3,174.765 107.579 3,507.329
202109 3,200.305 108.759 3,497.165
202112 3,192.813 109.676 3,459.801
202203 3,045.448 111.806 3,237.260
202206 2,971.635 114.083 3,095.751
202209 3,038.706 114.831 3,144.989
202212 3,319.296 115.200 3,424.392
202303 3,271.022 116.550 3,335.519
202306 3,497.452 117.140 3,548.442
202309 3,899.622 119.111 3,890.995
202312 3,673.446 118.848 3,673.446

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Hanall Biopharma Co  (XKRX:009420) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Hanall Biopharma Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=34750.00/2767.67
=12.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Hanall Biopharma Co was 21.95. The lowest was 5.28. And the median was 11.54.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Hanall Biopharma Co Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Hanall Biopharma Co's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanall Biopharma Co (XKRX:009420) Business Description

Traded in Other Exchanges
N/A
Address
12 Bongeunsa-ro 114-gil, Daewoong Building, 3rd Floor, Gangnam-gu, Seoul, KOR
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.

Hanall Biopharma Co (XKRX:009420) Headlines

No Headlines